Orexin receptor 1 signaling contributes to ethanol binge-like drinking: Pharmacological and molecular evidence

Behavioural Brain Research

Volumn 287, Issue , 2015, Pages 230-237

  Carvajal, Francisca ^b   Alcaraz Iborra, Manuel ^a   Lerma Cabrera, Jose Manuel ^b   Valor, Luis Miguel ^c   de la Fuente, Leticia ^a   Sanchez Amate, Maria del Carmen ^a   Cubero, Inmaculada ^a,b  

^a UNIVERSITY OF ALMERÍA   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

^c INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

Drinking in the dark (DID); Ethanol binge like consumption; Ethanol sedation; Orexins; OX receptor 1

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; ALCOHOL; OREXIN 1 RECEPTOR; SACCHARIN; 1-(2-METHYLBENZOXAZOL-6-YL)-3-(1,5)NAPHTHYRIDIN-4-YL UREA; ALCOHOL BLOOD LEVEL; BENZOXAZOLE DERIVATIVE; CENTRAL DEPRESSANT AGENT; DRINKING WATER; HYPNOTIC SEDATIVE AGENT; MESSENGER RNA; OREXIN RECEPTOR; OREXIN RECEPTOR ANTAGONIST; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINGE DRINKING; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG ACTIVITY; FOOD INTAKE; HOMEOSTASIS; LATENT PERIOD; LATERAL HYPOTHALAMUS; LOCOMOTION; MALE; METABOLISM; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPEATED DRUG DOSE; RIGHTING REFLEX; SEDATION; SIGNAL TRANSDUCTION; ALCOHOL BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DRUG EFFECTS; DRUG THERAPY; EATING; PHYSIOLOGY; REFLEX;

ANIMALS; BENZOXAZOLES; BINGE DRINKING; BLOOD ALCOHOL CONTENT; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DRINKING WATER; EATING; ETHANOL; HYPNOTICS AND SEDATIVES; HYPOTHALAMIC AREA, LATERAL; LOCOMOTION; MALE; MICE, INBRED C57BL; OREXIN RECEPTOR ANTAGONISTS; OREXIN RECEPTORS; REFLEX; RNA, MESSENGER; SACCHARIN; UREA;

EID: 84926463084     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.03.046     Document Type: Article

References (66)

1. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci 1998, 95:322-327.
2. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
3. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto M. Distribution of orexin neurons in the adult rat brain. Brain Res 1999, 827:243-260.
4. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
5. Bayer L., Eggermann E., Serafin M., Saint-Mleux B., Machard D., Jones B., et al. Orexins (hypocretins) directly excite tuberomammillary neurons. Eur J Neurosci 2001, 14:1571-1575.
6. Cason A.M., Smith R.J., Tahsili-Hahadan P., Moorman D.E., Sartor G.C., Aston-Jones G. Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity. Physiol Behav 2010, 100:419-428.
7. Sutcliffe J.G., de Lecea L. The hypocretins: setting the arousal threshold. Nat Rev Neurosci 2002, 3:339-349.
8. Zheng H., Patterson L.M., Berthoud H.R. Orexin signaling in the ventral tegmental area is required for high-fat appetite induced by opioid stimulation of the nucleus accumbens. J Neurosci 2007, 27:11075-11082.
9. Xu T.R., Yang Y., Ward R., Gao L., Liu Y. Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders. Cell Signal 2013, 25:2413-2423.
10. Taheri S., Hafizi S. The orexins/hypocretins: hypothalamic peptides linked to sleep and appetite. Psychol Med 2002, 32:955-958.
11. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
12. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98:365-376.
13. Girault E.M., Yi C.X., Fliers E., Kalsbeek A. Orexins, feeding and energy balance. Prog Brain Res 2012, 198:47-64.
14. Parker J.A., Bloom S.R. Hypothalamic neuropeptides and the regulation of appetite. Neuropharmacology 2012, 63:18-30.
15. Sakurai T., Mieda M. Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal. Trends Pharmacol Sci 2011, 32:451-462.
16. Mahler S.V., Smith R.J., Moorman D.E., Sartor G.C., Aston-Jones G. Multiple roles for orexin/hypocretin in addiction. Prog Brain Res 2012, 198:79-121.
17. van den Pol A.N., Gao X.B., Obrietan K., Kilduff T.S., Belousov A.B. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci 1998, 8:7962-7971.
18. Borgland S.L., Taha S.A., Sarti F., Fields H.L., Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006, 49:589-601.
19. Bonci A., Borgland S. Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system. Neuropharmacology 2009, 1:107-111.
20. Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci 2005, 102:19168-19173.
21. Fadel J., Deutch A.Y. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 2002, 111:379-387.
22. Harris G.C., Wimmer M., Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005, 437:556-559.
23. Martin-Fardon R., Zorrilla E.P., Ciccocioppo R., Weiss F. Role of innate and drug-induced dysregulation of brain stress and arousal systems in addiction: focus on corticotropin-releasing factor, nociceptin/orphanin FQ, and orexin/hypocretin. Brain Res 2010, 1314:145-161.
24. Narita M., Nagumo Y., Hashimoto S., Narita M., Khotib J., Miyatake M., et al. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviours induced by morphine. J Neurosci 2006, 26:398-405.
25. Mieda M., Sakurai T. Overview of orexin/hypocretin system. Prog Brain Res 2012, 198:5-14.
26. España R.A. Hypocretin/orexin involvement in reward and reinforcement. Vitam Horm 2012, 89:185-208.
27. Plaza-Zabala A., Maldonado R., Berrendero F. The hypocretin/orexin system: implications for drug reward and relapse. Mol Neurobiol 2012, 45:424-439.
28. Brown R.M., Lawrence A.J. Ascending orexinergic pathways and alcohol-seeking. Curr Opin Neurobiol 2013, 23:467-472.
29. Lawrence A.J., Cowen M.S., Yang H.J., Chen F., Oldfield B. The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 2006, 148:752-759.
30. Martin-Fardon R., Weiss F. N-(2-methyl-6-benzoxazolyl)-N'-1,5-naphthyridin-4-yl urea (SB334867), a hypocretin receptor-1 antagonist, preferentially prevents ethanol seeking: comparison with natural reward seeking. Addict Biol 2012, 19:233-236.
31. Richards J.K., Simms J.A., Steensland P., Taha S.A., Borgland S.L., Bonci A., et al. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 2008, 199:109-117.
32. Jupp B., Krivdic B., Krstew E., Lawrence A.J. The orexin-1 receptor antagonist SB-334867 dissociates the motivational properties of alcohol and sucrose in rats. Brain Res 2011, 1391:54-59.
33. Dhaher R., Hauser S.R., Getachew B., Bell R.L., McBride W.J., McKinzie D.L., et al. The orexin-1 receptor antagonist SB-334867 reduces alcohol relapse drinking, but not alcohol-seeking, in alcohol-preferring (P) rats. J Addict Med 2010, 4:153-159.
34. Shoblock J.R., Welty N., Aluisio L., Fraser I., Motley S.T., Morton K., et al. Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement. Psychopharmacology (Berl) 2011, 215:191-203.
35. Brown R.M., Khoo S.Y., Lawrence A.J. Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats. Int J Neuropsychopharmacol 2013, 16:2067-2079.
36. Moorman D.E., Aston-Jones G. Orexin-1 receptor antagonism decreases ethanol consumption and preference selectively in high-ethanol-preferring Sprague-Dawley rats. Alcohol 2009, 43:379-386.
37. Anderson R.I., Becker H.C., Adams B.L., Jesudason C.D., Rorick-Kehn L.M. Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models. Front Neurosci 2014, 25:8-33.
38. Thompson J.L., Borgland S.L. A role for hypocretin/orexin in motivation. Behav Brain Res 2011, 217:446-453.
39. Alcaraz-Iborra M., Carvajal F., Lerma-Cabrera J.M., Valor L.M., Cubero I. Binge-like consumption of caloric and non-caloric palatable substances in ad libitum-fed C57BL/6J mice: pharmacological and molecular evidence of orexin involvement. Behav Brain Res 2014, 272:93-99.
40. Jia X., Yan J., Xia J., Xiong J., Wang T., Chen Y., et al. Arousal effects of orexin A on acute alcohol intoxication-induced coma in rats. Neuropharmacology 2012, 62:775-783.
41. Kelz M.B., Sun Y., Chen J., Cheng Meng Q., Moore J.T., Veasey S.C., et al. An essential role for orexins in emergence from general anesthesia. Proc Natl Acad Sci U S A 2008, 105:1309-1314.
42. Shirasaka T., Yonaha T., Onizuka S., Tsuneyoshi I. Effects of orexin-A on propofol anesthesia in rats. J Anesth 2011, 25:65-71.
43. Kushikata T., Hirota K., Yoshida H., Kudo M., Lambert D.G., Smart D., et al. Orexinergic neurons and barbiturate anesthesia. Neuroscience 2003, 121:855-863.
44. Tose R., Kushikata T., Yoshida H., Kudo M., Furukawa K., Ueno S., et al. Orexin A decreases ketamine-induced anesthesia time in the rat: the relevance to brain noradrenergic neuronal activity. Anesth Analg 2011, 108:491-495.
45. Thiele T.E., Sparta D.R., Fee J.R., Navarro M., Cubero I. Central neuropeptide Y alters ethanol-induced sedation, but not ethanol intake, in C57BL/6 mice. Alcohol 2003, 31:155-160.
46. Smart D., Sabido-David C., Brough S.J., Jewitt F., Johns A., Porter R.A., et al. SB-334867-A: the first selective orexin-1 receptor antagonist. Br J Pharmacol 2001, 132:1179-1182.
47. Rhodes J.S., Best K., Belknap J.K., Finn D.A., Crabbe J.C. Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol Behav 2005, 84:53-63.
48. Rhodes J.S., Ford M.M., Yu C.H., Brown L.L., Finn D.A., Garland T., et al. Mouse inbred strain differences in ethanol drinking to intoxication. Genes Brain Behav 2007, 6:1-18.
49. Zhou Y., Bendor J., Hofmann L., Randesi M., Ho A., Kreek M.J. Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J Endocrinol 2006, 191:137-145.
50. Zhou Y., Cui C.L., Schlussman S.D., Choi J.C., Ho A., Han J.S., et al. Effects of cocaine place conditioning, chronic escalating-dose "binge" pattern cocaine administration and acute withdrawal on orexin/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats. Neuroscience 2008, 153:1225-1234.
51. Morganstern I., Chang G.Q., Barson J.R., Ye Z., Karatayev O., Leibowitz S.F. Differential effects of acute and chronic ethanol exposure on orexin expression in the perifornical lateral hypothalamus. Alcohol Clin Exp Res 2010, 34:886-896.
52. Furudono Y., Ando C., Yamamoto C., Kobashi M., Yamamoto T. Involvement of specific orexigenic neuropeptides in sweetener-induced overconsumption in rats. Behav Brain Res 2006, 15:241-248.
53. Navarro M., Cubero I., Ko L., Thiele T.E. Deletion of agouti-related protein blunts ethanol self-administration and binge-like drinking in mice. Genes Brain Behav 2009, 8:450-458.
54. Sparta D.R., Sparrow A.M., Lowery E.G., Fee J.R., Knapp D.J., Thiele T.E. Blockade of the corticotropin releasing factor type 1 receptor attenuates elevated ethanol drinking associated with drinking in the dark procedures. Alcohol Clin Exp Res 2008, 32:259-265.
55. Cubero I., Navarro M., Carvajal F., Lerma-Cabrera J.M., Thiele T.E. Ethanol-induced increase of agouti-related protein (AgRP) immunoreactivity in the arcuate nucleus of the hypothalamus of C57BL/6J, but not 129/SvJ, inbred mice. Alcohol Clin Exp Res 2010, 34:693-701.
56. Mahler S.V., Moorman D.E., Smith R.J., James M.H., Aston-Jones G. Motivational activation: a unifying hypothesis of orexin/hypocretin function. Nat Neurosci 2014, 17:1298-1303.
57. Mediavilla C., Cabello V., Risco S. SB-334867-A, a selective orexin-1 receptor antagonist, enhances taste aversion learning and blocks taste preference learning in rats. Pharmacol Biochem Behav 2011, 98:385-391.
58. Cason A.M., Aston-Jones G. Role of orexin/hypocretin in conditioned sucrose-seeking. Psychopharmacology (Berl) 2013, 226:155-165.
59. Borgland S.L., Chang S.J., Bowers M.S., Thompson J.L., Vittoz N., Floresco S.B., et al. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J Neurosci 2009, 29:11215-11225.
60. Cason A.M., Aston-Jones G. Attenuation of saccharin-seeking in rats by orexin/hypocretin receptor 1 antagonist. Psychopharmacology (Berl) 2013, 228:499-507.
61. Haynes A.C., Chapman H., Taylor C., Moore G.B., Cawthorne M.A., Tadayyon M., et al. Anorecic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice. Regul Pept 2002, 15:153-159.
62. Ishii Y., Blundell J.E., Halford J.C., Upton N., Porter R., Johns A., et al. Satiety enhancement by selective orexin-1 receptor anagonist SB-334867: influence of test context and profile comparison with CCK8-S. Behav Brain Res 2005, 160:11-24.
63. Rodgers R.J., Halford J.C., Nunes de Souza R.L., Canto de Souza A.L., Piper D.C., Arch J.R., et al. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioral satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci 2001, 13:1444-1452.
64. Parise E.M., Lilly N., Kay K., Dossat A.M., Seth R., Overton J.M., et al. Evidence for the role of hindbrain orexin-1 receptors in the control of meal size. Am J Physiol Regul Integr Comp Physiol 2011, 301:R1692-R1699.
65. Björnström K., Turina D., Strid T., Sundqvist T., Eintrei C. Orexin A inhibits propofol-induced neurite retraction by a phospholipase D/protein kinase Ce{open}-dependent mechanism in neurons. PLOS ONE 2014, 9(5):e97129.
66. Pickering C., Avesson L., Liljequist S., Lindblom J., Schiöth H.B. The role of hypothalamic peptide gene expression in alcohol self-administration behavior. Peptides 2007, 28:2361-2371.